Nephron-sparing resection of angiomyolipoma after sirolimus pretreatment in patients with tuberous sclerosis

International Urology and Nephrology

Volumn 44, Issue 6, 2012, Pages 1657-1661

  Staehler, Michael ^a   Sauter, Matthias ^a   Helck, Andreas ^a   Linsenmaier, Ulrich ^a   Weber, Lutz ^a   Mayer, Karin ^a,b   Fischereder, Michael ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Zentrum fuer Humangenetik und Laboratoriumsmedizin   (Germany)

Author keywords

Angiomyolipoma; mTOR inhibitor; Nephron sparing surgery; Renal function; Sirolimus; Tuberous sclerosis

Indexed keywords

ANTIBIOTIC AGENT; RAPAMYCIN; ANTINEOPLASTIC ANTIBIOTIC;

ADULT; ANEMIA; ARTICLE; CASE REPORT; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSLIPIDEMIA; FACE DISORDER; FACIAL CELLULITIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY HEMANGIOMYOLIPOMA; MALE; NEPHRON SPARING SURGERY; OUTCOME ASSESSMENT; PREOPERATIVE TREATMENT; PROTEINURIA; RASH; STOMATITIS; TUBEROUS SCLEROSIS; ANGIOMYOLIPOMA; CHILD; KIDNEY TUMOR; METHODOLOGY; NEPHRECTOMY; NEPHRON;

ANGIOMYOLIPOMA; ANTIBIOTICS, ANTINEOPLASTIC; CHILD; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; NEPHRECTOMY; NEPHRONS; SIROLIMUS; TUBEROUS SCLEROSIS; YOUNG ADULT;

EID: 84877617974     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-012-0292-z     Document Type: Article

References (22)

1. Paul E, Thiele E (2008) Efficacy of sirolimus in treating tuberous sclerosis and lymphangioleiomyomatosis. N Engl J Med 358(2):190-192. doi: 10.1056/NEJMe0707153
2. Curatolo P, Bombardieri R, Jozwiak S (2008) Tuberous sclerosis. Lancet 372(9639):657-668. doi: 10.1016/S0140-6736(08)61279-9
3. O'Callaghan FJ, Noakes MJ, Martyn CN, Osborne JP (2004) An epidemiological study of renal pathology in tuberous sclerosis complex. BJU Int 94(6):853-857. doi: 10.1111/j.1464-410X.2004.05046.x
4. Williams JM, Racadio JM, Johnson ND, Donnelly LF, Bissler JJ (2006) Embolization of renal angiomyolipomata in patients with tuberous sclerosis complex. Am J Kidney Dis 47(1):95-102. doi: 10.1053/j.ajkd.2005.09.028
5. Zimmerhackl LB, Rehm M, Kaufmehl K, Kurlemann G, Brandis M (1994) Renal involvement in tuberous sclerosis complex: a retrospective survey. Pediatr Nephrol 8(4):451-457
6. Shepherd CW, Gomez MR, Lie JT, Crowson CS (1991) Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 66(8):792-796
7. Ramon J, Rimon U, Garniek A, Golan G, Bensaid P, Kitrey ND, Nadu A, Dotan ZA (2009) Renal angiomyolipoma: long-term results following selective arterial embolization. Eur Urol 55(5):1155-1161. doi: 10.1016/j.eururo.2008.04.025
8. Boorjian SA, Frank I, Inman B, Lohse CM, Cheville JC, Leibovich BC, Blute ML (2007) The role of partial nephrectomy for the management of sporadic renal angiomyolipoma. Urology 70(6):1064-1068. doi: 10.1016/j.urology.2007.07.045
9. Sooriakumaran P, Gibbs P, Coughlin G, Attard V, Elmslie F, Kingswood C, Taylor J, Corbishley C, Patel U, Anderson C (2010) Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated. BJU Int 105(1):101-106. doi: 10.1111/j.1464-410X.2009.08649.x
10. Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA (2006) Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors. Kidney Int 70(10):1777-1782. doi: 10.1038/sj.ki.5001853
11. Seyam RM, Bissada NK, Kattan SA, Mokhtar AA, Aslam M, Fahmy WE, Mourad WA, Binmahfouz AA, Alzahrani HM, Hanash KA (2008) Changing trends in presentation, diagnosis and management of renal angiomyolipoma: comparison of sporadic and tuberous sclerosis complex-associated forms. Urology 72(5):1077-1082. doi: 10.1016/j.urology.2008.07.049
12. Clarke A, Hancock E, Kingswood C, Osborne JP (1999) End-stage renal failure in adults with the tuberous sclerosis complex. Nephrol Dial Transplant 14(4):988-991
13. Schillinger F, Montagnac R (1996) Chronic renal failure and its treatment in tuberous sclerosis. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association 11(3):481-485
14. Wienecke R, Fackler I, Linsenmaier U, Mayer K, Licht T, Kretzler M (2006) Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex. Am J Kidney Dis 48(3):e27-e29. doi: 10.1053/j.ajkd.2006.05.018
15. Bissler JJ, McCormack FX, Young LR, Elwing JM, Chuck G, Leonard JM, Schmithorst VJ, Laor T, Brody AS, Bean J, Salisbury S, Franz DN (2008) Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 358(2):140-151. doi: 10.1056/NEJMoa063564
16. Dabora SL, Franz DN, Ashwal S, Sagalowsky A, DiMario FJ Jr, Miles D, Cutler D, Krueger D, Uppot RN, Rabenou R, Camposano S, Paolini J, Fennessy F, Lee N, Woodrum C, Manola J, Garber J, Thiele EA (2011) Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease. PLoS One 6(9):e23379. doi: 10.1371/journal.pone.0023379
17. Davies DM, de Vries PJ, Johnson SR, McCartney DL, Cox JA, Serra AL, Watson PC, Howe CJ, Doyle T, Pointon K, Cross JJ, Tattersfield AE, Kingswood JC, Sampson JR (2011) Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial. Clin Cancer Res 17(12):4071-4081. doi: 10.1158/1078-0432.CCR-11-0445
18. Cabrera Lopez C, Marti T, Catala V, Torres F, Mateu S, Ballarin Castan J, Torra Balcells R (2011) Effects of rapamycin on angiomyolipomas in patients with tuberous sclerosis. Nefrologia 31(3):292-298. doi: 10.3265/Nefrologia. pre2011.Apr.10812
19. Lendvay TS, Marshall FF (2003) The tuberous sclerosis complex and its highly variable manifestations. J Urol 169(5):1635-1642. doi: 10.1097/01.ju.0000058253.40352.60
20. Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34(3):571-590
21. Krueger DA, Care MM, Holland K, Agricola K, Tudor C, Mangeshkar P, Wilson KA, Byars A, Sahmoud T, Franz DN (2010) Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med 363(19):1801-1811. doi: 10.1056/NEJMoa1001671
22. McCormack FX, Inoue Y, Moss J, Singer LG, Strange C, Nakata K, Barker AF, Chapman JT, Brantly ML, Stocks JM, Brown KK, Lynch JP III, Goldberg HJ, Young LR, Kinder BW, Downey GP, Sullivan EJ, Colby TV, McKay RT, Cohen MM, Korbee L, Taveira-DaSilva AM, Lee HS, Krischer JP, Trapnell BC, National Institutes of Health Rare Lung Diseases C, Group MT (2011) Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 364(17):1595-1606. doi: 10.1056/NEJMoa1100391